$52.60M Market Cap.
MDAI Market Cap. (MRY)
MDAI Shares Outstanding (MRY)
MDAI Assets (MRY)
Total Assets
$12.10M
Total Liabilities
$19.35M
Total Investments
$0
MDAI Income (MRY)
Revenue
$29.58M
Net Income
-$15.31M
Operating Expense
$19.86M
MDAI Cash Flow (MRY)
CF Operations
-$9.20M
CF Investing
$0
CF Financing
$9.57M
MDAI Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
|---|---|---|---|---|---|
2024 | $0 | 0% | 0% | 0% | - |
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | 0% | - | 0% | - |
MDAI Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $12,095,000 (13.12%) | $10,692,000 (-42.87%) | $18,716,000 (0.95%) | $18,539,000 |
Assets Current | $10,122,000 (2.22%) | $9,902,000 (-44.02%) | $17,687,000 (-4.22%) | $18,467,000 |
Assets Non-Current | $1,973,000 (149.75%) | $790,000 (-23.23%) | $1,029,000 (1329.17%) | $72,000 |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Shareholders Equity | -$7,251,000 (-324.28%) | -$1,709,000 (-114.25%) | $11,996,000 (-12.78%) | $13,753,000 |
Property Plant & Equipment Net | $1,973,000 (149.75%) | $790,000 (-23.23%) | $1,029,000 (3115.63%) | $32,000 |
Cash & Equivalents | $5,157,000 (7.66%) | $4,790,000 (-66.21%) | $14,174,000 (-12.08%) | $16,121,000 |
Accumulated Other Comprehensive Income | $3,000 (-75.00%) | $12,000 (0%) | $0 (0%) | $0 |
Deferred Revenue | $960,000 (-58.46%) | $2,311,000 (0%) | $0 (0%) | $0 |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Inventory | $425,000 (84.78%) | $230,000 (0%) | $0 (0%) | $0 |
Trade & Non-Trade Receivables | $2,505,000 (6.78%) | $2,346,000 (-19.44%) | $2,912,000 (93.36%) | $1,506,000 |
Trade & Non-Trade Payables | $4,035,000 (50.39%) | $2,683,000 (-2.75%) | $2,759,000 (95.12%) | $1,414,000 |
Accumulated Retained Earnings (Deficit) | -$48,103,000 (-46.71%) | -$32,788,000 (-174.74%) | -$11,934,000 (-32.28%) | -$9,022,000 |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Total Debt | $4,690,000 (263.85%) | $1,289,000 (7.33%) | $1,201,000 (106.00%) | $583,000 |
Debt Current | $2,988,000 (131.81%) | $1,289,000 (50.76%) | $855,000 (46.66%) | $583,000 |
Debt Non-Current | $1,702,000 (0%) | $0 (0%) | $346,000 (0%) | $0 |
Total Liabilities | $19,346,000 (56.00%) | $12,401,000 (84.54%) | $6,720,000 (40.41%) | $4,786,000 |
Liabilities Current | $17,644,000 (42.28%) | $12,401,000 (94.56%) | $6,374,000 (33.18%) | $4,786,000 |
Liabilities Non-Current | $1,702,000 (0%) | $0 (0%) | $346,000 (0%) | $0 |
MDAI Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $29,581,000 (63.83%) | $18,056,000 (-28.82%) | $25,368,000 (66.47%) | $15,239,000 |
Cost of Revenue | $16,307,000 (60.25%) | $10,176,000 (-29.97%) | $14,531,000 (77.49%) | $8,187,000 |
Selling General & Administrative Expense | $19,856,000 (-4.83%) | $20,864,000 (54.73%) | $13,484,000 (20.06%) | $11,231,000 |
Research & Development Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Operating Expenses | $19,856,000 (-4.83%) | $20,864,000 (54.73%) | $13,484,000 (20.06%) | $11,231,000 |
Interest Expense | $0 (0%) | $0 (0%) | $12,000 (-29.41%) | $17,000 |
Income Tax Expense | $271,000 (2363.64%) | $11,000 (-89.62%) | $106,000 (208.16%) | -$98,000 |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Consolidated Income | -$15,315,000 (26.56%) | -$20,854,000 (-616.14%) | -$2,912,000 (26.98%) | -$3,988,000 |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Net Income | -$15,315,000 (26.56%) | -$20,854,000 (-616.14%) | -$2,912,000 (26.98%) | -$3,988,000 |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $1,259,000 |
Net Income Common Stock | -$15,315,000 (26.56%) | -$20,854,000 (-616.14%) | -$2,912,000 (44.50%) | -$5,247,000 |
Weighted Average Shares | $17,934,218 (27.31%) | $14,087,586 (-89.60%) | $135,442,441 (35.05%) | $100,291,815 |
Weighted Average Shares Diluted | $17,934,218 (27.31%) | $14,087,586 (-89.60%) | $135,442,441 (35.05%) | $100,291,815 |
Earning Before Interest & Taxes (EBIT) | -$15,044,000 (27.82%) | -$20,843,000 (-645.99%) | -$2,794,000 (31.33%) | -$4,069,000 |
Gross Profit | $13,274,000 (68.45%) | $7,880,000 (-27.29%) | $10,837,000 (53.67%) | $7,052,000 |
Operating Income | -$6,582,000 (49.31%) | -$12,984,000 (-390.52%) | -$2,647,000 (36.66%) | -$4,179,000 |
MDAI Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | $0 (0%) | $0 (0%) | -$7,000 |
Net Cash Flow from Financing | $9,575,000 (149.09%) | $3,844,000 (589.68%) | -$785,000 (-105.64%) | $13,921,000 |
Net Cash Flow from Operations | -$9,199,000 (30.52%) | -$13,240,000 (-1039.41%) | -$1,162,000 (60.18%) | -$2,918,000 |
Net Cash Flow / Change in Cash & Cash Equivalents | $367,000 (103.91%) | -$9,384,000 (-381.97%) | -$1,947,000 (-117.71%) | $10,996,000 |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Capital Expenditure | $0 (0%) | $0 (0%) | $0 (0%) | -$7,000 |
Issuance (Repayment) of Debt Securities | $5,338,000 (1205.18%) | -$483,000 (38.47%) | -$785,000 (-11.98%) | -$701,000 |
Issuance (Purchase) of Equity Shares | $4,060,000 (21.16%) | $3,351,000 (0%) | $0 (0%) | $14,622,000 |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Effect of Exchange Rate Changes on Cash | -$9,000 (-175.00%) | $12,000 (0%) | $0 (0%) | $0 |
Share Based Compensation | $1,032,000 (-16.98%) | $1,243,000 (7.62%) | $1,155,000 (-15.38%) | $1,365,000 |
Depreciation Amortization & Accretion | $588,000 (-18.56%) | $722,000 (27.11%) | $568,000 (56700.00%) | $1,000 |
MDAI Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 44.90% (2.98%) | 43.60% (2.11%) | 42.70% (-7.78%) | 46.30% |
Profit Margin | -51.80% (55.15%) | -115.50% (-904.35%) | -11.50% (66.57%) | -34.40% |
EBITDA Margin | -48.90% (56.10%) | -111.40% (-1165.91%) | -8.80% (67.04%) | -26.70% |
Return on Average Equity (ROAE) | 342.60% (159.36%) | -577.20% (-1400.00%) | 44.40% (116.13%) | -275.30% |
Return on Average Assets (ROAA) | -115.40% (30.57%) | -166.20% (-10980.00%) | -1.50% (44.44%) | -2.70% |
Return on Sales (ROS) | -50.90% (55.89%) | -115.40% (-949.09%) | -11.00% (58.80%) | -26.70% |
Return on Invested Capital (ROIC) | 776.90% (-5.38%) | 821.10% (54840.00%) | -1.50% (31.82%) | -2.20% |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -3.33 (-100.30%) | -1.66 (99.67%) | -505 (-157.39%) | -196.2 |
Price to Sales Ratio (P/S) | 1.72 (-10.58%) | 1.92 (-96.44%) | 53.92 (-16.48%) | 64.56 |
Price to Book Ratio (P/B) | -7.25 (68.99%) | -23.4 (-187.87%) | 26.63 (18.04%) | 22.56 |
Debt to Equity Ratio (D/E) | -2.67 (63.23%) | -7.26 (-1395.71%) | 0.56 (60.92%) | 0.35 |
Earnings Per Share (EPS) | -0.85 (42.57%) | -1.48 (-7300.00%) | -0.02 (60.00%) | -0.05 |
Sales Per Share (SPS) | 1.65 (28.63%) | 1.28 (585.56%) | 0.19 (23.03%) | 0.15 |
Free Cash Flow Per Share (FCFPS) | -0.51 (45.43%) | -0.94 (-10344.44%) | -0.01 (68.97%) | -0.03 |
Book Value Per Share (BVPS) | -0.4 (-233.88%) | -0.12 (-235.96%) | 0.09 (-35.04%) | 0.14 |
Tangible Assets Book Value Per Share (TABVPS) | 0.67 (-11.20%) | 0.76 (450.00%) | 0.14 (-25.41%) | 0.18 |
Enterprise Value Over EBIT (EV/EBIT) | -4 (-100.00%) | -2 (98.25%) | -114 (-50.00%) | -76 |
Enterprise Value Over EBITDA (EV/EBITDA) | -3.94 (-131.09%) | -1.71 (98.81%) | -143.26 (-88.37%) | -76.05 |
Asset Turnover | 2.23 (54.90%) | 1.44 (1006.92%) | 0.13 (66.67%) | 0.08 |
Current Ratio | 0.57 (-28.07%) | 0.8 (-71.24%) | 2.77 (-28.09%) | 3.86 |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Free Cash Flow (FCF) | -$9,199,000 (30.52%) | -$13,240,000 (-1039.41%) | -$1,162,000 (60.27%) | -$2,925,000 |
Enterprise Value (EV) | $56,958,247 (66.00%) | $34,312,140 (-89.24%) | $318,894,662 (3.08%) | $309,377,476 |
Earnings Before Tax (EBT) | -$15,044,000 (27.82%) | -$20,843,000 (-642.80%) | -$2,806,000 (31.33%) | -$4,086,000 |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$14,456,000 (28.15%) | -$20,121,000 (-803.91%) | -$2,226,000 (45.28%) | -$4,068,000 |
Invested Capital | -$6,016,000 (-15.47%) | -$5,210,000 (-725.67%) | -$631,000 (64.65%) | -$1,785,000 |
Working Capital | -$7,522,000 (-201.00%) | -$2,499,000 (-122.09%) | $11,313,000 (-17.31%) | $13,681,000 |
Tangible Asset Value | $12,095,000 (13.12%) | $10,692,000 (-42.87%) | $18,716,000 (0.95%) | $18,539,000 |
Market Capitalization | $52,604,247 (31.55%) | $39,987,140 (-87.48%) | $319,412,500 (2.96%) | $310,241,250 |
Average Equity | -$4,470,000 (-223.71%) | $3,613,250 (155.04%) | -$6,564,723 (-444.49%) | $1,905,655 |
Average Assets | $13,269,250 (5.72%) | $12,551,000 (-93.57%) | $195,298,895 (-0.10%) | $195,498,610 |
Invested Capital Average | -$1,936,500 (23.71%) | -$2,538,500 (-101.35%) | $187,811,418 (-0.70%) | $189,129,466 |
Shares | 18,588,073 (14.35%) | 16,254,935 (-48.60%) | 31,625,000 (0.00%) | 31,625,000 |
